- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07573254
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With Mechanical Low Back Pain
1 mai 2026 mis à jour par: Mirsad Alkan, Istinye University
The Effects of Spinal Mobilization Added to an Exercise Program on Pain and Physical Fitness in Recreational Tennis Players With Mechanical Low Back Pain
This prospective, single-blind, randomized controlled trial investigates whether the addition of spinal mobilization to a structured home exercise program improves pain, flexibility, lower-extremity strength, dynamic balance, and jump performance in recreational tennis players (aged 18-45 years; BMI 18-30 kg/m²) with non-radiating mechanical low back pain.
Participants were allocated to two parallel groups: a Control Group performing a 21-session home exercise program for 3 weeks, and an Experimental Group performing the same program plus four physiotherapist-administered spinal mobilization sessions (one at baseline and one weekly for 3 weeks).
Outcomes were the Visual Analog Scale (VAS) for pain during physical activity, at rest, and at night; the Y-Balance Test; the Vertical Jump Test; the Sit-and-Reach Test; and isometric strength measured with a back-chest-leg dynamometer.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Design: prospective, randomized, single-blind, parallel-group controlled clinical trial.
The study was conducted under the supervision of the Department of Physiotherapy and Rehabilitation, Chiropractic Master's Program.
Recreational tennis players (aged 18-45 years; BMI 18-30 kg/m²) with mechanical low back pain of more than 1 week duration and a baseline pain intensity exceeding 4 on the Visual Analog Scale (VAS) who played tennis at least twice per week (≥2 hours/week) were enrolled after providing written informed consent.
Allocation was performed using sealed opaque envelopes combined with computer-assisted randomization, with masking applied to the outcome assessor.
Participants were randomized to: (1) Control Group (CG) - structured home exercise program comprising posterior pelvic tilt, erector spinae stretching (double knee-to-chest), combined hamstring/lumbar extensor stretching (long-sit toe touch), piriformis stretching, and static hamstring stretching (5 repetitions of 30-second holds for stretches; 5 repetitions of 10-second holds for posterior pelvic tilt); the program was performed daily for 21 sessions over 3 weeks and supported by written instructions, visual materials, and weekly telephone follow-up; (2) Experimental Group (EG) - the identical home exercise program plus four sessions of supervised spinal mobilization delivered by a physiotherapist (one at baseline and once weekly for 3 weeks).
Mobilization was administered according to the Maitland classification (graded I to V; end-range was not forced) and included thoracic posteroanterior mobilization (T5-T12), rotational thoracic mobilization ("butterfly/screw" technique), sacroiliac mobilization, side-lying lumbar mobilization, and anteroposterior lumbar mobilization.
Each technique was applied as five sets of one-minute oscillations with 20-second rest intervals across the posteroanterior, mediolateral, and transverse planes.
Outcome assessments were performed at baseline (Week 0) and at the end of the intervention (Week 3) by a single blinded assessor.
Pain was quantified with three 10-cm Visual Analog Scales (physical activity, rest, and night).
Dynamic balance was assessed with the Y-Balance Test in three directions (anterior, posteromedial, posterolateral).
Lower-extremity power was measured with the Vertical Jump Test using the validated My Jump Lab application (iPhone 15 Pro Max).
Hamstring and lumbar flexibility were measured with a Baseline sit-and-reach box.
Isometric strength of the back, chest, and leg extensors was measured with a calibrated Baseline back-chest-leg dynamometer (New York, USA).
Statistical plan: normality was tested by Shapiro-Wilk; within-group changes were analysed by paired-samples t-test, between-group differences by independent-samples t-test, and categorical variables by Chi-square; Cohen's d was calculated for parameters with significant within-group changes.
Analyses were performed in IBM SPSS 25.0.
A priori sample size estimation (G*Power 3.1.9.2) with 85% power, an effect size of d = 0.8, and α = 0.05 yielded a target of 30 participants; 32 were enrolled to allow for attrition.
Post hoc power analysis based on the post-intervention VAS during physical activity (d = 1.24, α = 0.05) yielded a power of 0.91.
No external funding; no conflicts of interest declared.
Type d'étude
Interventionnel
Inscription (Réel)
31
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Istanbul, Turquie (Türkiye)
- Istinye University
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- Adults aged 18-45 years.
- Body mass index (BMI) between 18 and 30 kg/m².
- Mechanical low back pain that decreases in the supine position and increases with activity or in various postures.
- Low back pain of more than one week duration with a baseline intensity greater than 4 on the Visual Analog Scale (VAS) and unrelated to any defined medical condition.
- Playing tennis on a recreational basis at least 2 days per week, totalling at least 2 hours per week.
- Able to communicate in Turkish or English in both written and spoken form.
Exclusion Criteria:
- Pain in the lower back, hip, or groin lasting longer than 6 months.
- Pain accompanied by a sensory deficit.
- Pain radiating to the hip or lower extremity.
- History of long-term steroid use.
- Regular medication use.
- History of injury or surgery resulting in residual deficits.
- Previous interventional treatment to the lumbar region.
- Pregnancy or suspected pregnancy.
Termination Criteria During Study:
- Onset of an acute illness requiring treatment (e.g., influenza, pneumonia).
- Use of analgesic or sedative medication.
- An increase in VAS pain score greater than 3 points during exercise or treatment.
- Failure to perform the home exercise programme on three consecutive days.
- Missed manual therapy session.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Control Group (CG):Home Exercise Program Only
Structured home-based exercise program performed daily for 3 weeks (21 sessions).
The program included posterior pelvic tilt, double knee-to-chest erector spinae stretching, combined hamstring and lumbar extensor stretching (long-sit toe touch), piriformis stretching, and static hamstring stretching.
Adherence was supported by written instructions, visual materials, and weekly telephone follow-up.
|
21 daily sessions over 3 weeks; 5 repetitions per exercise (30-second holds for stretches; 10-second hold for posterior pelvic tilt); supported by written instructions, visual materials, and weekly telephone follow-up.
|
|
Expérimental: Experimental Group (EG): Spinal Mobilization Plus Home Exercise Program
The identical home exercise program (21 sessions over 3 weeks) plus four sessions of supervised spinal mobilization administered by a physiotherapist - one at baseline and one per week for 3 weeks - using Maitland-graded techniques (Levels I-V; end-range not forced).
|
21 daily sessions over 3 weeks; 5 repetitions per exercise (30-second holds for stretches; 10-second hold for posterior pelvic tilt); supported by written instructions, visual materials, and weekly telephone follow-up.
Four supervised sessions over 3 weeks (one at baseline and weekly thereafter).
Techniques included thoracic posteroanterior mobilization (T5-T12), rotational thoracic mobilization ("butterfly/screw"), sacroiliac mobilization, side-lying lumbar mobilization, and anteroposterior lumbar mobilization.
Each technique was applied as five sets of one-minute oscillations with 20-second rest intervals in the posteroanterior, mediolateral, and transverse planes.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Visual Analog Scale (VAS) for pain during physical activity (cm
Délai: Baseline to Week 3
|
Self-reported pain intensity during physical activity recorded on a 10-cm horizontal Visual Analog Scale anchored from 0 ("no pain") to 10 ("worst imaginable pain").
Lower values indicate less pain.
Safety Issue: No.
|
Baseline to Week 3
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Visual Analog Scale (VAS) for pain at rest (cm)
Délai: Baseline to Week 3
|
Self-reported pain intensity at rest recorded on a 10-cm horizontal Visual Analog Scale anchored from 0 ("no pain") to 10 ("worst imaginable pain").
Lower values indicate less pain.
Safety Issue: No.
|
Baseline to Week 3
|
|
Visual Analog Scale (VAS) for night pain (cm)
Délai: Baseline to Week 3
|
Self-reported pain intensity during sleep/night recorded on a 10-cm horizontal Visual Analog Scale anchored from 0 ("no pain") to 10 ("worst imaginable pain").
Lower values indicate less pain.
Safety Issue: No.
|
Baseline to Week 3
|
|
Y-Balance Test (cm)
Délai: Baseline to Week 3
|
Dynamic balance and neuromuscular control assessed by the maximum reach distance for each lower extremity in three directions (anterior, posteromedial, posterolateral).
Three trials per leg per direction; the maximum reach distance for each direction is recorded.
Higher values indicate better dynamic postural control.
Safety Issue: No.
|
Baseline to Week 3
|
|
Vertical Jump Test (cm)
Délai: Baseline to Week 3
|
Maximal vertical jump height assessed using the validated My Jump Lab smartphone application (iPhone 15 Pro Max mounted on a flexible tripod 20 cm above the ground).
Three trials are performed barefoot on a hard surface with hands fixed on the hips; minimum, maximum, and mean values are recorded.
Higher values indicate better lower-extremity power.
Safety Issue: No.
|
Baseline to Week 3
|
|
Sit-and-Reach Test (cm)
Délai: Baseline to Week 3
|
Hamstring and lumbar flexibility assessed using a Baseline sit-and-reach box.
From a long-sit position with the feet flat against the box and the knees fully extended, the participant reaches forward with both hands three times; the maximum reach distance from the foot reference line is recorded (positive when reaching beyond the toes; negative when not reaching the toes).
Higher values indicate greater flexibility.
Safety Issue: No.
|
Baseline to Week 3
|
|
Isometric Back-Chest-Leg Strength (kg-force)
Délai: Baseline to Week 3
|
Maximal isometric strength of the back, chest, and lower-extremity extensor chain measured with a calibrated Baseline back-chest-leg dynamometer (New York, USA).
Following one practice trial, three trials are performed with 30-second rest intervals; the highest value is used in analysis.
Higher values indicate greater isometric strength.
Safety Issue: No.
|
Baseline to Week 3
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 avril 2025
Achèvement primaire (Réel)
1 août 2025
Achèvement de l'étude (Réel)
20 août 2025
Dates d'inscription aux études
Première soumission
1 mai 2026
Première soumission répondant aux critères de contrôle qualité
1 mai 2026
Première publication (Réel)
7 mai 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
7 mai 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
1 mai 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Tennis - Spinal Mob 25-49
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
INDÉCIS
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .